Sally Yang Email

Associate Director Regulatory Affairs . Codagenix

Farmingdale, NY

Location

s****@codagenix.com

Primary Email

Current Roles

Employees:
40
Revenue:
$6.2M
About
Codagenix Inc. is a clinical stage biotechnology company with vaccine products against influenza, respiratory syncytial virus, dengue virus, and others currently under development. Codagenix uses a computer-based algorithm, called SAVE (Synthetic Attenuated Virus Engineering) to design viral genomes that are identical to the wild type strain at the amino acid level, but make less protein in human cells. The highly attenuated viruses make excellent vaccines or oncolytics against solid tumors. Codagenix represents the next wave in vaccine technology, untethered from traditional, time-consuming and unpredictable approaches to attenuating viruses.
Codagenix Address
3 Bioscience Park Drive
Farmingdale, NY
United States
Codagenix Email

Past Companies

Codagenix, Inc.Associate Director Regulatory Affairs
Synchrogenix, a Certara companyAssociate Director, Regulatory Program Management
Clinical Network Services (CNS) Pty LtdConsultant, BioDesk

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.